Abstract
Laryngeal cancer is the second most common cancer of the respiratory tract with a relative 5-year survival over all tumour sites in the USA (61.6%; SEER 2009), which is much better than other head and neck cancers. The aim of this paper is to review and summarise data on the survival of laryngeal cancer patients. Literature search was conducted to identify articles in PubMed up to June 2009. Thirty studies with different study aims including sufficient information on survival of laryngeal cancer patients were identified. The 5-year overall survival ranged from 0 to 100%, depending on the T- and N-category, therapeutic approach and tumour location. The involvement of other factors such as genetics, nutrition and lifestyle habits remains uncertain. Our meta-analysis on a subgroup of published studies yielded an overall 5-year relative survival rate of 64.2% (95% confidence interval 63.7–64.7%). Different study aims and patient selection criteria prohibit general conclusions. However, this review may provide an actual picture of the complexity of factors influencing the survival of laryngeal cancer patients.
Similar content being viewed by others
References
Ferlay J, Bray F, Pisani P, Parkin D (2001) GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. IARC cancer base no. 5, IARC, Lyon, version 1.0
Ramroth H, Dietz A, Becher H (2004) Interaction effects and population-attributable risks for smoking and alcohol on laryngeal cancer and its subsites. A case–control study from Germany. Methods Inf Med 43:499–504. doi:10.1267/METH04050499
Shangina O, Brennan P, Szeszenia-Dabrowska N, Mates D, Fabiánová E, Fletcher T et al (2006) Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. Am J Epidemiol 164:367–375. doi:10.1093/aje/kwj208
Talamini R, Bosetti C, Vecchia CL, Maso LD, Levi F, Bidoli E et al (2002) Combined effect of tobacco and alcohol on laryngeal cancer risk: a case–control study. Cancer Causes Control 13:957–964
Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D et al (2007) Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol 165:814–820. doi:10.1093/aje/kwk066
IARC (2003) Monographs on the evaluation of carcinogenic risks to humans tobacco smoke and involuntary smoking. IARC, Lyon, p 83
Ramroth H, Dietz A, Becher H (2008) Environmental tobacco smoke and laryngeal cancer: results from a population-based case–control study. Eur Arch Otorhinolaryngol 265:1367–1371. doi:10.1007/s00405-008-0651-7
Lee YCA, Boffetta P, Sturgis EM, Wei Q, Zhang ZF, Muscat J et al (2008) Involuntary smoking and head and neck cancer risk: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev 17:1974–1981. doi:10.1158/1055-9965.EPI-08-0047
Becher H, Ramroth H, Ahrens W, Risch A, Schmezer P, Dietz A (2005) Occupation, exposure to polycyclic aromatic hydrocarbons and laryngeal cancer risk. Int J Cancer 116:451–457. doi:10.1002/ijc.21049
Ramroth H, Dietz A, Ahrens W, Becher H (2008) Occupational wood dust exposure and the risk of laryngeal cancer: a population based case–control study in Germany. Am J Ind Med 51:648–655. doi:10.1002/ajim.20605
Boffetta P, Richiardi L, Berrino F, Estève J, Pisani P, Crosignani P et al (2003) Occupation and larynx and hypopharynx cancer: an international case–control study in France, Italy, Spain, and Switzerland. Cancer Causes Control 14:203–212
Dietz A, Ramroth H, Urban T, Ahrens W, Becher H (2004) Exposure to cement dust, related occupational groups and laryngeal cancer risk: results of a population based case–control study. Int J Cancer 108:907–911. doi:10.1002/ijc.11658
http://seer.cancer.gov/csr/1975_2006/results_merged/topic_survival.pdf
Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R et al (2009) EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 45:931–991. doi:10.1016/j.ejca.2008.11.018
Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ et al (2006) American society of clinical oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24:3693–3704. doi:10.1200/JCO.2006.07.4559
Holsinger FC, Weber RS (2007) Swing of the surgical pendulum: a return to surgery for treatment of head and neck cancer in the 21st century? Int J Radiat Oncol Biol Phys 69:S129–S131. doi:10.1016/j.ijrobp.2007.05.044
Boscolo-Rizzo P, Maronato F, Marchiori C, Gava A, Mosto MCD (2008) Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation. Laryngoscope 118:300–306. doi:10.1097/MLG.0b013e31815a9ed3
Chen AY, Matson LK, Roberts D, Goepfert H (2001) The significance of comorbidity in advanced laryngeal cancer. Head Neck 23:566–572
Piccirillo JF, Lacy PD, Basu A, Spitznagel EL (2002) Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg 128:1172–1179
Sabin SL, Rosenfeld RM, Sundaram K, Har-el G, Lucente FE (1999) The impact of comorbidity and age on survival with laryngeal cancer. Ear Nose Throat J 78:578, 581–578, 584
Castro MAF, Dedivitis RA, Ribeiro KCB (2007) Comorbidity measurement in patients with laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 69:146–152. doi:10.1159/000099223
Dietz A, Boehm A, Mozet C, Wichmann G, Giannis A (2008) Current aspects of targeted therapy in head and neck tumors. Eur Arch Otorhinolaryngol 265(Suppl 1):S3–S12. doi:10.1007/s00405-008-0697-6
Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:3582–3589. doi:10.1200/JCO.2007.14.8841
Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101:498–506. doi:10.1093/jnci/djp007
Lefebvre JL, Ang KK, Panel LPC (2009) Larynx preservation clinical trial design: key issues and recommendations—a consensus panel summary. Int J Radiat Oncol Biol Phys 73:1293–1303
Dietz A, Boehm A, Horn IS, Kruber P, Bechmann I, Golusinski W et al (2010) Assay-based response evaluation in head and neck oncology: requirements for better decision making. Eur Arch Otorhinolaryngol 267:483–494. doi:10.1007/s00405-009-1191-5
Wittekind C, Sobin L (2002) TNM classification of malignant tumours. Wiley-Liss, New York
Molina MA, Cheung MC, Perez EA, Byrne MM, Franceschi D, Moffat FL et al (2008) African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer 113:2797–2806. doi:10.1002/cncr.23889
Sutton A, Abrams K, Jones D, Sheldon T, Song F (2000) Methods for meta-analysis in medical research. Wiley, Chichester
Cantor AB (2001) Projecting the standard error of the Kaplan–Meier estimator. Stat Med 20:2091–2097. doi:10.1002/sim.856
Dikshit RP, Boffetta P, Bouchardy C, Merletti F, Crosignani P, Cuchi T et al (2005) Lifestyle habits as prognostic factors in survival of laryngeal and hypopharyngeal cancer: a multicentric European study. Int J Cancer 117:992–995. doi:10.1002/ijc.21244
Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269. doi:10.1093/jnci/djn011
Adamopoulos G, Yotakis I, Apostolopoulos K, Manolopoulos L, Kandiloros D, Ferekidis E (1997) Supraglottic laryngectomy-series report and analysis of results. J Laryngol Otol 111:730–734
Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ et al (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116:1–13. doi:10.1097/01.mlg.0000236095.97947.26
Rachet B, Quinn MJ, Cooper N, Coleman MP (2008) Survival from cancer of the larynx in England and Wales up to 2001. Br J Cancer 99(Suppl 1):S35–S37. doi:10.1038/sj.bjc.6604581
Raitiola H, Pukander J, Laippala P (1999) Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis. Acta Otolaryngol 119:847–851
LaRosa F, Petrinelli AM, Stracci F, Ammetto C, Casucci P, Mastrandrea V (2000) Long term survival of upper aerodigestive tract cancer in male patients in the Umbria region (Italy). Eur J Epidemiol 16:489–494
Tamura Y, Tanaka S, Asato R, Hirano S, Yamashita M, Tamaki H, et al. (2007) Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years. Acta Otolaryngol Suppl, pp 62–65. doi:10.1080/00016480601067990
DiMartino E, Sellhaus B, Hausmann R, Minkenberg R, Lohmann M, Esthofen MW (2002) Survival in second primary malignancies of patients with head and neck cancer. J Laryngol Otol 116:831–838. doi:10.1258/00222150260293664
Olthoff A, Ewen A, Wolff H, Hermann R, Vorwerk H, Hille A et al (2009) Organ function and quality of life after transoral laser microsurgery and adjuvant radiotherapy for locally advanced laryngeal cancer. Strahlenther Onkol 185:303–309. doi:10.1007/s00066-009-1967-y
Fung K, Lyden TH, Lee J, Urba SG, Worden F, Eisbruch A et al (2005) Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 63:1395–1399. doi:10.1016/j.ijrobp.2005.05.004
Preuss SF, Cramer K, Klussmann JP, Eckel HE, Guntinas-Lichius O (2009) Transoral laser surgery for laryngeal cancer: outcome, complications and prognostic factors in 275 patients. Eur J Surg Oncol 35:235–240. doi:10.1016/j.ejso.2008.01.012
Cabanillas R, Rodrigo JP, Llorente JL, Suárez C (2008) Oncologic outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck 30:750–755. doi:10.1002/hed.20778
Motta S, Moscillo L, Imperiali M, Motta G (2003) CO2 laser treatment of bilateral vocal cord paralysis in adduction. ORL J Otorhinolaryngol Relat Spec 65:359–365. doi:10.1159/000076055
Hartl DM, de Monès E, Hans S, Janot F, Brasnu D (2007) Treatment of early-stage glottic cancer by transoral laser resection. Ann Otol Rhinol Laryngol 116:832–836
Ansarin M, Santoro L, Cattaneo A, Massaro MA, Calabrese L, Giugliano G et al (2009) Laser surgery for early glottic cancer: impact of margin status on local control and organ preservation. Arch Otolaryngol Head Neck Surg 135:385–390. doi:10.1001/archoto.2009.10
Hinni ML, Salassa JR, Grant DG, Pearson BW, Hayden RE, Martin A et al (2007) Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133:1198–1204. doi:10.1001/archotol.133.12.1198
Prades JM, Simon PG, Timoshenko AP, Dumollard JM, Schmitt T, Martin C (2005) Extended and standard supraglottic laryngectomies: a review of 110 patients. Eur Arch Otorhinolaryngol 262:947–952. doi:10.1007/s00405-004-0882-1
Pellini R, Pichi B, Ruscito P, Ceroni AR, Caliceti U, Rizzotto G et al (2008) Supracricoid partial laryngectomies after radiation failure: a multi-institutional series. Head Neck 30:372–379. doi:10.1002/hed.20709
Piazza C, Peretti G, Cattaneo A, Garrubba F, Zinis LORD, Nicolai P (2007) Salvage surgery after radiotherapy for laryngeal cancer: from endoscopic resections to open-neck partial and total laryngectomies. Arch Otolaryngol Head Neck Surg 133:1037–1043. doi:10.1001/archotol.133.10.1037
Santos CR, Kowalski LP, Magrin J, Fogaroli RC, Santos JC, Sabóia MV et al (1998) Prognostic factors in supraglottic carcinoma patients treated by surgery or radiotherapy. Ann Otol Rhinol Laryngol 107:697–702
Sevilla MA, Rodrigo JP, Llorente JL, Cabanillas R, López F, Suárez C (2008) Supraglottic laryngectomy: analysis of 267 cases. Eur Arch Otorhinolaryngol 265:11–16. doi:10.1007/s00405-007-0415-9
Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW (2001) T1–T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 19:4029–4036
Reddy SP, Hong RL, Nagda S, Emami B (2007) Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience. Int J Radiat Oncol Biol Phys 69:1389–1394. doi:10.1016/j.ijrobp.2007.05.077
Kao J, Lavaf A, Teng MS, Huang D, Genden EM (2008) Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys 71:362–370. doi:10.1016/j.ijrobp.2007.09.058
Rusthoven KE, Raben D, Chen C (2008) Improved survival in patients with stage III–IV head and neck cancer treated with radiotherapy as primary local treatment modality. Int J Radiat Oncol Biol Phys 72:343–350. doi:10.1016/j.ijrobp.2007.12.046
Nguyen-Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffinet DR et al (2001) Treatment results and prognostic factors of advanced T3–4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys 50:1172–1180
Spector JG, Sessions DG, Lenox J, Simpson J (2006) Management of T3N1 glottic carcinoma: therapeutic outcomes. Laryngoscope 116:106–110. doi:10.1097/01.mlg.0000184767.62682.3d
MacKenzie RG, Franssen E, Balogh JM, Gilbert RW, Birt D, Davidson J (2000) Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery. Int J Radiat Oncol Biol Phys 47:65–71
Herchenhorn D, Dias FL, Ferreira CG, Araújo CM, Lima RA, Small IA et al (2008) Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation. ORL J Otorhinolaryngol Relat Spec 70:381–388. doi:10.1159/000163034
Johnson J (2006) Outcomes in laryngeal cancer: a product of the learning curve? Laryngoscope 116:1529. doi:10.1097/01.mlg.0000236092.52123.a9
Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952
Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944
Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial. EORTC head and neck cancer cooperative group. J Natl Cancer Inst 88:890–899
The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690. doi:10.1056/NEJM199106133242402
Pignon JP, le Maître A, Maillard E, Bourhis J, MACHNCC Group (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiother Oncol 92:4–14. doi:10.1016/j.radonc.2009.04.014
Higgins KM, Wang JR (2008) State of head and neck surgical oncology research—a review and critical appraisal of landmark studies. Head Neck 30:1636–1642. doi:10.1002/hed.20863
Dietz A, Rudat V, Dreyhaupt J, Pritsch M, Hoppe F, Hagen R et al (2009) Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Eur Arch Otorhinolaryngol 266:1291–1300. doi:10.1007/s00405-008-0846-y
Forastiere AA, Trotti A, Pfister DG, Grandis JR (2006) Head and neck cancer: recent advances and new standards of care. J Clin Oncol 24:2603–2605. doi:10.1200/JCO.2006.07.1464
Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY et al (2004) Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 130:875–879. doi:10.1001/archotol.130.7.875
Oates J, Clark JR, Read J, Reeves N, Gao K, O’Brien CJ (2008) Integration of prospective quality of life and nutritional assessment as routine components of multidisciplinary care of patients with head and neck cancer. ANZ J Surg 78:34–41. doi:10.1111/j.1445-2197.2007.04353.x
Hoffmann M, Görögh T, Gottschlich S, Lohrey C, Rittgen W, Ambrosch P et al (2005) Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett 218:199–206. doi:10.1016/j.canlet.2004.09.027
Acknowledgments
The work of Elisabeth Rudolph was supported in part by a DFG grant from the GRK 793 Graduate College: “Epidemiology of communicable and chronic, non-communicable diseases and their interrelationships” at the University Hospital at Heidelberg.
Conflict of interest
The authors declare no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rudolph, E., Dyckhoff, G., Becher, H. et al. Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis. Eur Arch Otorhinolaryngol 268, 165–179 (2011). https://doi.org/10.1007/s00405-010-1395-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-010-1395-8